Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568)
Your solution for detecting and studying the crucial enzyme involved in the metabolism of tuberculosis-causing bacteria.
This highly specific antibody targets the icl1/isocitrate lyase 1 protein, which plays a crucial role in the survival and virulence of Mycobacterium tuberculosis. By binding to this protein, the Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) allows for the detection and analysis of this essential enzyme.
But what exactly is the biological function of icl1/isocitrate lyase 1 and why is it important in the context of tuberculosis? This enzyme is involved in the glyoxylate shunt pathway, which is crucial for the survival of M. tuberculosis in the host. This pathway allows the bacteria to utilize fatty acids as a source of energy, making it a key factor in the pathogenesis of tuberculosis.
The Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) has a variety of applications in the field of biotechnology. It can be used in immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA) to detect the presence of icl1/isocitrate lyase 1 in samples. This makes it a valuable tool for researchers studying the metabolism and virulence of M. tuberculosis.
In addition, this antibody has been successfully used in experimental studies to understand the role of icl1/isocitrate lyase 1 in tuberculosis infection and to identify potential targets for drug development. Its high specificity and sensitivity make it a reliable tool for these types of studies.
When it comes to researching tuberculosis, accuracy and efficiency are key. The Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) offers both. So why wait? Add the Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) to your research targets today and take the first step towards understanding the crucial role of icl1/isocitrate lyase 1 in tuberculosis.
There are no reviews yet.